MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Viatris Total Inventories 2011-2026 | VTRS
Annual Total Inventories Viatris
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 B | 3.85 B | 3.47 B | 3.52 B | 3.98 B | 5.47 B | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.47 B | 3.47 B | 4.05 B |
Quarterly Total Inventories Viatris
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.93 B | 4.11 B | 4.26 B | 4.1 B | 4.08 B | 3.94 B | - | - | 3.64 B | 3.66 B | 3.52 B | 3.38 B | 3.61 B | 3.8 B | 3.98 B | 4.08 B | 4.49 B | 4.94 B | 5.47 B | 5.47 B | 5.47 B | 5.47 B | 2.67 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.47 B | 2.67 B | 4.19 B |
Total Inventories of other stocks in the Drug manufacturers industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
246 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
445 K | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
6.23 M | $ 5.68 | -0.79 % | $ 84.4 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
1.18 M | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
106 K | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
1.24 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
40.4 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
2.74 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
1.88 M | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
46.8 M | $ 2.77 | -0.72 % | $ 1.06 B |  Canada |
 |
Athenex
ATNX
|
42.7 M | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
13.5 M | $ 36.85 | 10.13 % | $ 1.35 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
20.3 M | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
574 M | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
47.8 M | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
29.6 M | $ 2.53 | 1.81 % | $ 321 M | USA |
 |
Canopy Growth Corporation
CGC
|
96.4 M | $ 1.02 | 0.49 % | $ 110 M | Canada |
 |
Pacira BioSciences
PCRX
|
125 M | $ 23.65 | 1.9 % | $ 1.09 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
2.92 M | $ 1.09 | -1.8 % | $ 1.35 M | USA |
 |
Jupiter Wellness
JUPW
|
949 K | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
95.2 M | - | 1.15 % | $ 7.11 M | USA |
 |
Tilray
TLRY
|
201 M | $ 5.16 | -0.19 % | $ 3.19 B | Canada |
 |
Evolus
EOLS
|
27 M | $ 6.76 | 0.9 % | $ 436 M | USA |
 |
Emergent BioSolutions
EBS
|
343 M | $ 8.18 | 3.09 % | $ 438 M | USA |
 |
Veru
VERU
|
4.14 M | $ 3.09 | -0.32 % | $ 45.3 M | USA |
 |
cbdMD
YCBD
|
2.95 M | $ 0.7 | -1.68 % | $ 2.82 M | USA |
 |
Assertio Holdings
ASRT
|
24.1 M | $ 23.49 | 0.11 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
70 K | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
11.4 M | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
1.63 B | $ 5.27 | 1.84 % | $ 1.95 B | Canada |
 |
PetIQ
PETQ
|
159 M | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
10.3 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
11.5 M | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
899 K | $ 4.28 | -1.95 % | $ 214 M | USA |
 |
PLx Pharma
PLXP
|
2.46 M | - | -27.8 % | $ 2.56 M | USA |
 |
Zomedica Corp.
ZOM
|
5.54 M | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
3.42 M | $ 0.66 | -3.66 % | $ 23.7 M | USA |
 |
China Pharma Holdings
CPHI
|
1.62 M | $ 0.76 | 5.54 % | $ 3.26 M |  China |
 |
TherapeuticsMD
TXMD
|
7.99 M | $ 1.86 | -1.06 % | $ 21.5 M | USA |